C4 Therapeutics, Inc. (CCCC)

NASDAQ: CCCC · Real-Time Price · USD

2.670

+0.080 (3.09%)

At close: Dec 5, 2025, 4:00 PM EST

2.710

+0.040 (1.50%)

Pre-market: Dec 8, 2025, 4:39 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Targeted Protein Degradation	35.58M	Log In	Log In	Log In	Log In	Upgrade
Targeted Protein Degradation Growth	71.44%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
United States	35.58M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	71.44%	Log In	Log In	Log In	Log In	Upgrade